(Q33600259)

English

Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

0 references

Manuel Vincente Sanchez-Felix

object named as

Manuel V Sanchez-Felix

7

0 references

author name string

David P McDonnell

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Holland C Detke

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Richard F Bergstrom

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Prajakti Kothare

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Jason Johnson

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Mary Stickelmeyer

6

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Sebastian Sorsaburu

8

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Malcolm I Mitchell

9

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

10 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

45

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

copyright license

Creative Commons Attribution 2.0 Generic

10 June 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1186/1471-244x-10-45

0 references

Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2895590

21 June 2018

Olanzapine long-acting injection: a 24-week, randomized, double-blind trial of maintenance treatment in patients with schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2895590

21 June 2018

Complications after unintentional intra-arterial injection of drugs: risks, outcomes, and management strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2895590

21 June 2018

Olanzapine plasma concentrations and clinical response: acute phase results of the North American Olanzapine Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2895590

21 June 2018

Safe injection techniques

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2895590

21 June 2018

Delusions induced by procaine penicillin: case report and review of the syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2895590

21 June 2018

Systemic Toxic Reactions to Procaine Penicillin G

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2895590

21 June 2018

In vitro and in vivo considerations associated with parenteral sustained release products: a review based upon information presented and points expressed at the 2007 Controlled Release Society Annual Meeting

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-45

21 January 2018

Olanzapine plasma concentrations after treatment with 10, 20, and 40 mg/d in patients with schizophrenia: an analysis of correlations with efficacy, weight gain, and prolactin concentration.

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-45

21 January 2018

Branch retinal artery occlusion after injection of a long-acting risperidone preparation.

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-45

21 January 2018

Analysis of olanzapine in human plasma utilizing reversed-phase high-performance liquid chromatography with electrochemical detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/20537130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-244X-10-45

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33600259&oldid=1870304550"